Synthesis and evaluation of novel biaryl oxazolidinones effective against gram-positive bacterial infections

被引：0

作者：

Bhawsar, Satish ^{[1
]}

Shaikh, Mohammad ^{[1
]}

Joshi, Sanjeev ^{[1
]}

Mishra, Amit ^{[1
]}

Pavase, Laxmikant ^{[1
]}

Chavan, Vijay ^{[1
]}

Kale, Amol ^{[1
]}

Kayastha, Abhijeet K. ^{[1
]}

Yeole, Ravindra ^{[1
]}

Bhagwat, Sachin ^{[1
]}

Patel, Mahesh ^{[1
]}

机构：

[1] MIDC, Wockhardt Res Ctr, D-4, Aurangabad 431006, Maharashtra, India

来源：

MEDICINAL CHEMISTRY RESEARCH | 2024年 / 33卷 / 10期

关键词：

Biaryl oxazolidinones; antibiotics; gram-positive; MRSA; WCK; 3999; 4603;

D O I：

10.1007/s00044-024-03287-z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Oxazolidinones are synthetic antibiotic class of compounds characterized by chemical structure, cyclic carbamate with 'S' configuration of substituent at C-5 position. The synthesis of oxazolidinones has gained increasing interest due to their unique mechanism of action that assures high antibiotic efficiency and low susceptibility to resistance mechanisms. Biaryl oxazolidinones are second-generation oxazolidinone (e.g. Tedizolid) having potency against multidrug-resistant (MDR) gram-positive pathogens including MRSA, VRE, penicillin-resistant S. pneumoniae and linezolid-resistant strains. The current manuscript covers structure activity based synthesis of 21 oxazolidinone analogs prepared through various chemical modifications. These novel biaryl oxazolidinones are prepared with the objective to increase spectrum of activity against multidrug-resistant Gram-positive bacteria. [GRAPHICS] .

引用

页码：1887 / 1896

页数：10

共 50 条

[1] Phage therapy as a revolutionary medicine against Gram-positive bacterial infections
Loganathan, Archana
Manohar, Prasanth
Eniyan, Kandasamy
VinodKumar, C. S.
Leptihn, Sebastian
Nachimuthu, Ramesh
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2021, 10 (01)
[2] Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin
Nailor, Michael D.
Sobel, Jack D.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (04) : 965 - +
[3] Novel agents for the treatment of resistant Gram-positive infections
Woodford, N
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 117 - 137
[4] Identification of a Novel Protein Synthesis Inhibitor Active against Gram-Positive Bacteria
Eibergen, Nora R.
Im, Isak
Patel, Nisha Y.
Hergenrother, Paul J.
CHEMBIOCHEM, 2012, 13 (04) : 574 - 583
[5] Tedizolid: A Novel Oxazolidinone for Gram-Positive Infections
Moellering, Robert C., Jr.
CLINICAL INFECTIOUS DISEASES, 2014, 58 : S1 - S3
[6] Design, synthesis, and antibacterial evaluation of a novel series of biaryloxazolidinone derivatives against Gram-positive bacteria
Qi, Yinliang
Ding, Xiudong
Wang, Kun
Yan, Pingzhen
Guo, Xinxin
Ma, Shiwei
Xiao, Mingfei
Sun, Pengrui
Liu, Siyu
Hou, Yunlei
Zhao, Yanfang
NEW JOURNAL OF CHEMISTRY, 2022, 46 (19) : 9470 - 9485
[7] Efficacy and safety of dalbavancin in the treatment of Gram-positive bacterial infections
Wang, Yuhang
Wang, Jin
Wang, Rui
Li, Yuanyuan
Cai, Yun
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 : 72 - 80
[8] Daptomycin therapy for invasive Gram-positive bacterial infections in children
Ardura, Monica I.
Mejias, Asuncion
Katz, Kathy S.
Revell, Paula
McCracken, George H., Jr.
Sanchez, Pablo J.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (12) : 1128 - 1132
[9] In vitro Antimicrobial Activity of Royleanone Derivatives Against Gram-Positive Bacterial Pathogens
Rijo, Patricia
Duarte, Aida
Francisco, Ana Paula
Semedo-Lemsaddek, Teresa
Simoes, Maria Fatima
PHYTOTHERAPY RESEARCH, 2014, 28 (01) : 76 - 81
[10] Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
Zhu, Xiaoli
Hong, Anjin
Sun, Xihuan
Wang, Weijie
He, Guanghui
Luo, Huan
Wu, Zhenhua
Xu, Qingyan
Hu, Zhiyu
Wu, Xiaobing
Huang, Donghong
Li, Li
Zhao, Xilin
Deng, Xianming
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12

← 1 2 3 4 5 →